The long-term goal of these studies is to understand cytokine-based mechanisms responsible for curative and noncurative immune responses during leishmaniasis. A well-characterized model of murine leishmaniasis has already provided important insights into the cytokine pathology of this disease. Progression of L. major infection from cutaneous to visceral sites in susceptible BALB/c mice is mediated by expansion of the Th2 CD4+ lymphocyte subset and production of IL-4. Although IFN-gamma and Th1 CD4+ cell development are necessary for cure in resistant C57BL/6 mice and in BALB/c mice protectively treated with anti-IL-4 antibodies, IFN-gamma therapy does not restore curative immunity in BALB/c mice. Based on our preliminary data, we propose that IL-12 may be a more effective immunotherapeutic agent for Th2-mediated illnesses. IL-12 is a heterodimeric T-cell growth and IFN-gamma stimulatory cytokine that is produced by B-cells and macrophages and that is known to promote Th1 and suppress Th2 cell responses in vitro. Our preliminary studies confirm the ability of IL-12 to cure susceptible BALB/c mice and to durably suppress Th2 immune responses when administered early during infection with L. major. Treatment of resistant C57BL/6 mice with anti-IL-12 antibodies exacerbates disease. We hypothesize that IL-12 strongly inhibits Th2 T cell responses, that suppression of IL-12 synthesis and function during infection causes Th2- mediated progression of disease, and that IL-12 has potential as an immunotherapeutic agent in leishmaniasis and other Th2-mediated parasitic diseases. We propose experiments to explore further the basic biology of IL-12 production and function during leishmaniasis and to identify immunotherapeutic uses in the mouse model that may suggest clinical applications.
Specific aims are to: 1) Examine the role of IL-12 in regulating CD4+ subset selection and curative immunity in disease-susceptible BALB/c mice and resistant C57BL/6 mice infected with Leishmania major. 2) Identify differences in the production of IL-12 by BALB/c and C57BL/6 mice during leishmaniasis. 3) Develop uses for IL-12 as a therapeutic modulator of immune responses during established leishmaniasis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI035979-01
Application #
2071987
Study Section
Special Emphasis Panel (SRC (40))
Project Start
1994-09-01
Project End
1998-05-31
Budget Start
1994-09-01
Budget End
1995-05-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Greene, Jennifer A; DeVecchio, Jennifer L; Gould, Meetha P et al. (2006) In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN. J Immunol 176:5995-6003
Yadavalli, Gopala K; Chien, Jason W; Wener, Kenneth M et al. (2005) Interleukin 12 and interferon-gamma synthetic deficiency is associated with dendritic cell cytopenia after cardiac surgery. Shock 24:26-33
Das, Lopamudra; DeVecchio, Jennifer; Heinzel, Frederick P (2005) Fms-like tyrosine kinase 3-based immunoprophylaxis against infection is improved by adjuvant treatment with anti-interleukin-10 antibody. J Infect Dis 192:693-702
Gould, Meetha P; Greene, Jennifer A; Bhoj, Vijay et al. (2004) Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis. J Immunol 172:1754-62
Murray, Henry W; Brooks, Elaine B; DeVecchio, Jennifer L et al. (2003) Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis. Antimicrob Agents Chemother 47:2513-7
Garhart, Christine A; Nedrud, John G; Heinzel, Frederick P et al. (2003) Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun 71:3628-33
Murray, Henry W; Lu, Cristina M; Brooks, Elaine B et al. (2003) Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis. Infect Immun 71:6453-62
Garhart, Christine A; Heinzel, Frederick P; Czinn, Steven J et al. (2003) Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent. Infect Immun 71:910-21
Murray, Henry W; Moreira, Andre L; Lu, Cristina M et al. (2003) Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J Infect Dis 188:458-64
Khatri, Saloni; Lass, Jonathan H; Heinzel, Fred P et al. (2002) Regulation of endotoxin-induced keratitis by PECAM-1, MIP-2, and toll-like receptor 4. Invest Ophthalmol Vis Sci 43:2278-84

Showing the most recent 10 out of 24 publications